Combination of biomarkers for detecting and evaluating a hepatic fibrosis
US12110551B2 · kind B2 · utility
0Cited by
9References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 28, 2021 |
| Grant date | Oct 8, 2024 |
| Priority date | — |
| Expiry date | May 3, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7052
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The application concerns means for determining the stage of hepatic tissue damage, in particular the hepatic fibrosis score of subjects infected with one or more hepatitis viruses. In particular, the means of the invention involve measuring the levels of expression of selected genes, said selected genes being:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.